RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment

Radiation therapy is a staple approach for cancer treatment, whereas radioresistance of cancer cells remains a substantial clinical problem. In response to ionizing radiation (IR) induced DNA-damage, cancer cells can sustain/activate pro-survival signaling pathways, leading to apoptotic resistance a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hein, Ashley L., Post, Carl M., Sheinin, Yuri M., Lakshmanan, Imayavaramban, Natarajan, Amarnath, Enke, Charles A., Batra, Surinder K., Ouellette, Michel M., Yan, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112160/
https://www.ncbi.nlm.nih.gov/pubmed/27181206
http://dx.doi.org/10.1038/onc.2016.163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112160/
https://www.ncbi.nlm.nih.gov/pubmed/27181206
http://dx.doi.org/10.1038/onc.2016.163

Ejemplares similares